These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market

A recent report by Morgan Stanley predicts a greater than 40 percent growth in the Hepatitis C (HCV) market in 2015. Projections indicate that the HCV market could be worth $15 billion in upcoming years, with two-thirds of treatment occurring in the United States.

HCV Forerunners Gilead And AbbVie

Morgan Stanley projects that Gilead Sciences, Inc.’s GILD 1.93% Harvoni and Sovaldi and AbbVie Inc’s ABBV 2.02% soon-to-be-approved drug cocktail will account for a large part of the market share for HCV treatment in upcoming years. Analysts project $11 billion in sales for Gilead’s HCV business in 2015 and $10.5 billion in 2016. Projections for AbbVie’s HCV business the next two years total $3.6 billion and $4.0 billion respectively.

Treatment Costs

As it stands, Gilead’s Sovaldi treatment costs patients about $1,000 per day for either 12 or 24 weeks. Harvoni treatment costs $1,125 per day for either eight, 12 or 24 weeks. Until AbbVie’s 4-pill daily HCV treatment officially launches (analysts predict mid-January), firm predictions for the market are difficult to make.

Will The HCV Market Be Taken By These Two?

Morgan Stanley analysts Matthew Harrison and David Risinger are forecasting…

Read the rest of this article (and all my other articles) for free on Benzinga by clicking here

Want to learn more about the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!